Effectiveness of blood flow restriction training after bone-patellar tendon-bone anterior cruciate ligament reconstruction: a randomized placebo-controlled trial

Effectiveness of blood flow restriction training after bone-patellar tendon-bone anterior cruciate ligament reconstruction: a randomized placebo-controlled trial - Effectiveness of blood flow restriction training after ACL

Status

Active, not recruiting

Phases

Phase 3

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON49262

Enrollment

Registered

2020-04-06

Start date

2020-07-09

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anterior cruciate ligament (ACL) reconstruction

Interventions

None listed

Eligibility

Age

12 Years to 99 Years

Inclusion criteria

Inclusion criteria: Patients who underwent primary bone-patellar tendon-bone anterior cruciate ligament reconstruction

Exclusion criteria

Exclusion criteria: Patients known with • diabetes • sickle cell anemia • severe hypertension • renal compromise • venous thromboembolism • extremity infection • lymphadenectomy • cancer

Design outcomes

Primary

Measure	Time frame
Primary outcomes are: quadriceps and hamstring strength 8-, 14-, 26-, 39- and 52-weeks after BPTB ACL reconstruction.	—

Secondary

Measure	Time frame
Secondary outcomes are leg muscle size, physical function, patient satisfaction, patient confidence, knee laxity, knee pain and knee effusion 8-, 14-, 26-, 39- and 52-weeks after BPTB ACL reconstruction. Furthermore, completion of revalidation and adverse events will be documented.	—

Countries

Netherlands

Outcome results